O. Zenker
Inflarx (Germany)(DE)
Publications by Year
Research Areas
Immunodeficiency and Autoimmune Disorders, Platelet Disorders and Treatments, Blood groups and transfusion, Chronic Lymphocytic Leukemia Research, Pneumocystis jirovecii pneumonia detection and treatment
Most-Cited Works
- → Efficacy and Safety of a New 20% Immunoglobulin Preparation for Subcutaneous Administration, IgPro20, in Patients With Primary Immunodeficiency(2010)131 cited
- → Efficacy and safety of Hizentra® in patients with primary immunodeficiency after a dose-equivalent switch from intravenous or subcutaneous replacement therapy(2011)118 cited
- → Pharmacokinetics of subcutaneous immunoglobulin and their use in dosing of replacement therapy in patients with primary immunodeficiencies(2011)108 cited
- → Complement activation in hidradenitis suppurativa: a new pathway of pathogenesis?(2018)79 cited
- → Efficacy and safety of Privigen® in patients with chronic inflammatory demyelinating polyneuropathy: results of a prospective, single‐arm, open‐label Phase III study (the PRIMA study)(2013)75 cited
- → Clinical efficacy of complement C5a inhibition by IFX‐1 in hidradenitis suppurativa: an open‐label single‐arm trial in patients not eligible for adalimumab(2020)59 cited
- → Efficacy and Safety of Hizentra®, a New 20% Immunoglobulin Preparation for Subcutaneous Administration, in Pediatric Patients with Primary Immunodeficiency(2011)50 cited
- → Efficacy and safety of Privigen®, a novel liquid intravenous immunoglobulin formulation, in adolescent and adult patients with chronic immune thrombocytopenic purpura(2009)48 cited
- → Carimune NF Liquid is a Safe and Effective Immunoglobulin Replacement Therapy in Patients with Primary Immunodeficiency Diseases(2007)23 cited
- → Efficacy and safety of intravenous anti-D immunoglobulin (Rhophylac®) in chronic immune thrombocytopenic purpura(2007)12 cited